Literature DB >> 1873207

Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide.

N P Burrows1, M J Walport, A H Hammond, N Davey, R R Jones.   

Abstract

A female patient with disfiguring lupus erythematosus profundus (LEP) from the age of 13 years was found to have an isolated partial C4 deficiency, with reduced levels of both allotypes, C4A and C4B. A genetic basis for the hypocomplementaemia was confirmed by a family study of complement and HLA types which revealed heterozygous null alleles for C4A and C4B in the proband. Marked improvement in her cutaneous lesions occurred with thalidomide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1873207     DOI: 10.1111/j.1365-2133.1991.tb06042.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Update on management of connective tissue panniculitides.

Authors:  Inbal Braunstein; Victoria P Werth
Journal:  Dermatol Ther       Date:  2012 Mar-Apr       Impact factor: 2.851

2.  Diagnosis and management of systemic lupus erythematosus. Thalidomide modifies disease.

Authors:  N P Burrows
Journal:  BMJ       Date:  1993-10-09

3.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

4.  Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene.

Authors:  D Tsambaos; K Bolsen; S Georgiou; A Monastirli; G Goerz
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.

Authors:  Anna Wozniacka; Małgorzata Salamon; Aleksandra Lesiak; Daniel Paul McCauliffe; Anna Sysa-Jedrzejowska
Journal:  Clin Rheumatol       Date:  2006-04-28       Impact factor: 3.650

6.  Case report on a patient with lupus panniculitis.

Authors:  Agata Bednarek; Leszek Bartoszak; Włodzimierz Samborski
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.